PH, L., CJ, C., JS, T., ZR, Z., KC, C., CH, C., . . . GC, C. (2023). Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma. Frontiers in oncology, 13, 1096683. https://doi.org/10.3389/fonc.2023.1096683
Chicago Style (17th ed.) CitationPH, Lee, et al. "Adjuvant Chemotherapy Compared with Observation in Patients with T2aN0 Stage IB Lung Adenocarcinoma." Frontiers in Oncology 13 (2023): 1096683. https://doi.org/10.3389/fonc.2023.1096683.
MLA (9th ed.) CitationPH, Lee, et al. "Adjuvant Chemotherapy Compared with Observation in Patients with T2aN0 Stage IB Lung Adenocarcinoma." Frontiers in Oncology, vol. 13, 2023, p. 1096683, https://doi.org/10.3389/fonc.2023.1096683.
Warning: These citations may not always be 100% accurate.
